Literature DB >> 20030997

Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.

D Kumar1, V Ramesh, S Verma, M Ramam, P Salotra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20030997     DOI: 10.1179/000349809X12554106963438

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


× No keyword cloud information.
  10 in total

Review 1.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

2.  Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.

Authors:  Shamim Islam; Eben Kenah; Mohammed Ashraful Alam Bhuiyan; Kazi Mizanur Rahman; Brook Goodhew; Chowdhury Mohammad Ghalib; M M Zahid; Masayo Ozaki; M W Rahman; Rashidul Haque; Stephen P Luby; James H Maguire; Diana Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2013-07-01       Impact factor: 2.345

3.  Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis.

Authors:  Sankha Koley; Rajesh Kumar Mandal; Sanjiv Choudhary; Arghya Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

4.  Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).

Authors:  Gajendra Kumar Katara; Nasim Akhtar Ansari; Avninder Singh; V Ramesh; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

5.  PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.

Authors:  Swagata Ganguly; Pabitra Saha; Moytrey Chatterjee; Surajit Roy; Tamal Kanti Ghosh; Subhasish K Guha; Pratip K Kundu; Dilip K Bera; Nandita Basu; Ardhendu K Maji
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

Review 6.  Post kala-azar dermal leishmaniasis: an unresolved mystery.

Authors:  Debanjan Mukhopadhyay; Jane E Dalton; Paul M Kaye; Mitali Chatterjee
Journal:  Trends Parasitol       Date:  2014-01-02

Review 7.  Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

Authors:  Eduard E Zijlstra; Fabiana Alves; Suman Rijal; Byron Arana; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2017-11-16

Review 8.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

9.  Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal.

Authors:  Ritika Sengupta; Surya Jyati Chaudhuri; Srija Moulik; Manab Kumar Ghosh; Bibhuti Saha; Nilay Kanti Das; Mitali Chatterjee
Journal:  PLoS Negl Trop Dis       Date:  2019-03-11

10.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.